Persian Gulf Syndrome
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2027.
Clinical MilestonesViewHide
- 2026-05-01Coenzyme Q10 for Gulf War Illness: A Replication StudyResults expected Q4 2027
- 2026-05-01ClinicalCoenzyme Q10 for Gulf War Illness: A Replication StudyResults expected Q4 2027
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Persian Gulf Syndrome1
- Stress Disorders, Post-Traumatic1
- Veterans1
Leading journals1
- Military Medical Research1
Leading researchers8
- Abreu M1
- Aenlle K1
- Collado F1
- Craddock TJA1
- Hardy J1
- Kasarla R1
- Klimas N1
- Shastry N1
Affiliations (unnormalised)5
- Boston University School of Public Health1
- Department of Clinical Immunology1
- Institute for Neuro-Immune Medicine1
- Miami Veterans Affairs Medical Center1
- Nova Southeastern University1
Reference
Authoritative identity, definition & identifiers.
Unexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. (Nature 1994 May 5;369(6475):8)
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.